Screener
Chemours CC Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Chemours in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Chemours’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 11:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001627223-26-000024
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from life insurance policies | 1 | — |
| Proceeds from sales of assets and businesses | 294 | 1 |
| Foreign exchange contract settlements, net | (7) | (2) |
| Cash provided by (used for) investing activities | 195 | (128) |
| Cash flows from financing activities | ||
| Proceeds from issuance of debt | 700 | 95 |
| Debt repayments | (963) | (111) |
| Payments on finance leases | (5) | (7) |
Item 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Chemours's investing cash flow?
- Chemours (CC) reported investing cash flow of $239M in Q2 2026.
- How has Chemours's investing cash flow changed year-over-year?
- Chemours's investing cash flow increased by 669.0% year-over-year, from -$42M to $239M.
- What is the long-term trend for Chemours's investing cash flow?
- Over 3 years (2021 to 2025), Chemours's investing cash flow has grown at a -2.2% compound annual growth rate (CAGR), from $220M to -$206M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Chemours's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude